These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23784854)

  • 1. Pattern of the epitope-specific IgG/IgM response against human cytomegalovirus in patients with multiple myeloma.
    Bogner E; Pecher G
    Clin Vaccine Immunol; 2013 Aug; 20(8):1298-304. PubMed ID: 23784854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins.
    Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Enders G; Jahn G; Plachter B
    J Virol Methods; 1996 Jun; 60(1):73-80. PubMed ID: 8795008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of blood donors for human cytomegalovirus (HCMV) IgG antibody with an enzyme immunoassay using recombinant antigens.
    Weber B; Fall EM; Berger A; Doerr HW
    J Clin Virol; 1999 Dec; 14(3):173-81. PubMed ID: 10614854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin A and M patterns to human cytomegalovirus during recurrent infection in patients with AIDS using a modified western blot.
    Braun W; Weber B; Moell U; Hamann A; Doerr HW
    J Virol Methods; 1993 Jun; 43(1):65-75. PubMed ID: 8395539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of anti-p52 IgM and anti-gB IgG by ELISA as a novel diagnostic tool for detection of early and late phase of primary human cytomegalovirus infections during pregnancy.
    Zelini P; Fornara C; Furione M; Sarasini A; Klemens J; Arossa A; Spinillo A; Gerna G; Lilleri D
    J Clin Virol; 2019 Nov; 120():38-43. PubMed ID: 31546089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern and persistence of the epitope-specific IgM response against human cytomegalovirus in renal transplant patients.
    Müller TF; Gicklhorn D; Jungraithmayr T; Eickmann M; Lange H; Radsak K; Reschke M
    J Clin Virol; 2002 Feb; 24(1-2):45-56. PubMed ID: 11744428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen.
    Xi H; Jinjie L; Shengxiang G; Tingdong L; Han W; Xiaoyi G; Tong-Ming F; Jun Z
    J Virol Methods; 2017 Feb; 240():21-25. PubMed ID: 27825854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
    Beqaj SH; Lerner AM; Fitzgerald JT
    J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
    van Zanten J; Harmsen MC; van der Giessen M; van der Bij W; Prop J; de Leij L; The TH
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):214-8. PubMed ID: 7535179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.
    Weber B; Braun W; Cinatl J; Doerr HW
    Clin Investig; 1993 Apr; 71(4):270-6. PubMed ID: 8386033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus (HCMV)-specific T cell but not neutralizing or IgG binding antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Zavaglio F; Rampino T; Perez L; Gabanti E; Gerna G
    J Med Virol; 2018 Oct; 90(10):1620-1628. PubMed ID: 29797330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.
    Lang D; Vornhagen R; Rothe M; Hinderer W; Sonneborn HH; Plachter B
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):747-56. PubMed ID: 11427421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the indirect and IgM-capture anti-human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidity.
    Ikuta K; Koshizuka T; Kanno R; Inoue N; Kubo T; Koyano S; Suzutani T
    Microbiol Immunol; 2019 May; 63(5):172-178. PubMed ID: 31012489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of serological diagnosis of human cytomegalovirus infection in renal transplant recipients by testing for specific immunoglobulin E by ELISA.
    Weber B; Stemmler A; Ernst W; Scheuerman EH; Braun W; Doerr HW
    Infection; 1993; 21(3):158-63. PubMed ID: 8396070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an in-house specific immunoglobulin G (IgG) avidity ELISA for distinguishing recent primary from long-term human cytomegalovirus (HCMV) infection.
    de Souza S; Bonon SH; Costa SC; Rossi CL
    Rev Inst Med Trop Sao Paulo; 2003; 45(6):323-6. PubMed ID: 14762632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive predictive value of anti-HCMV IgM as an index of primary infection.
    De Paschale M; Agrappi C; Manco MT; Clerici P
    J Virol Methods; 2010 Sep; 168(1-2):121-5. PubMed ID: 20470827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of an in-house assay for cytomegalovirus immunoglobulin G (CMV IgG) avidity and relationship of avidity to CMV IgM levels.
    Prince HE; Leber AL
    Clin Diagn Lab Immunol; 2002 Jul; 9(4):824-7. PubMed ID: 12093680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving diagnosis of primary cytomegalovirus infection in pregnant women using immunoblots.
    Rajasekariah H; Scott G; Robertson PW; Rawlinson WD
    J Med Virol; 2013 Feb; 85(2):315-9. PubMed ID: 23171986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.
    Dollard SC; Staras SA; Amin MM; Schmid DS; Cannon MJ
    Clin Vaccine Immunol; 2011 Nov; 18(11):1895-9. PubMed ID: 21918114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey.
    Ibrahim S; Siddiqui AA; Siddiqui AR; Ahmed W; Moss PA; Lalani EM
    BMC Public Health; 2016 Oct; 16(1):1112. PubMed ID: 27770770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.